![]() |
市场调查报告书
商品编码
1750568
冻干设备市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测Lyophilization Equipment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
2024年,全球冻干设备市场价值为70亿美元,预计到2034年将以8.8%的复合年增长率增长,达到161亿美元,这主要得益于癌症、糖尿病和心血管疾病等慢性疾病的日益流行。随着包括生物製剂、疫苗和其他敏感药物在内的长期治疗需求的增长,对冷冻干燥设备的需求也随之增长。
冷冻干燥是製药和生物製药行业必不可少的工艺,因为它有助于保持敏感治疗药物(包括疫苗、生物製剂和注射剂)的功效、稳定性和保质期。冷冻干燥过程透过冷冻干燥去除水分,确保这些产品即使在严苛的储存条件下也能长时间保持完整性。对于需要长期或持续治疗的慢性疾病,例如癌症、糖尿病和心血管疾病,冷冻干燥过程尤其重要。随着这些疾病在全球的盛行率持续上升,预计对冷冻干燥产品的需求将大幅增加。对这些持久、无水分治疗药物的需求直接影响冷冻干燥设备市场的成长。随着製药和生物製药公司不断开发需要专门储存解决方案的新型疗法,对冷冻干燥製程的依赖也将日益增长。
市场范围 | |
---|---|
起始年份 | 2024 |
预测年份 | 2025-2034 |
起始值 | 70亿美元 |
预测值 | 161亿美元 |
复合年增长率 | 8.8% |
2024年,设备细分市场产值达到37亿美元,这得益于市场对自动化、高通量、节能型冷冻干燥设备(例如旋转式冻干机和托盘式冷冻干燥机)日益增长的需求。这些设备尤其适用于大规模生产热敏性产品,包括生物製剂和疫苗。此外,冷冻干燥技术的不断进步,例如即时监控能力以及对温度和真空度等关键参数控制的改进,正在提升这些设备的效率,使其对製药和生物製药行业更具吸引力。
桌上型冷冻干燥设备市场在2024年占据46.3%的市场份额,预计到2034年将达到75亿美元。桌上型设备因其紧凑的设计、高性价比以及包括精确真空和温度控制在内的先进功能,在实验室、药物开发和学术研究机构等小规模生产环境中备受青睐。这些特性使桌上型冷冻干燥设备成为实验研究和早期製剂开发的理想选择。
受美国癌症发生率上升的推动,预计2034年,美国冷冻干燥设备市场规模将达到47亿美元。随着癌症治疗技术的不断发展,许多製药和生物技术公司正在投资开发稳定、先进的疗法,例如疫苗和注射。冻干技术支持这些肿瘤治疗药物的大规模生产,进一步推动市场扩张。
全球冷冻干燥设备市场的主要参与者包括阿自倍尔 (Azbil)、GEA Group Aktiengesellschaft、MechaTech Systems、Millrock Technology 和 WL Gore & Associates 等公司。这些公司专注于创新,并不断扩展产品线,以巩固其市场地位。例如,Labconco 和 ZIRBUS technology 等公司强调节能且用户友好的解决方案,而 Optima 和 Cuddon 等公司则正在探索整合先进的监控系统和自动化技术,以提高设备性能和可靠性。
The Global Lyophilization Equipment Market was valued at USD 7 billion in 2024 and is estimated to grow at a CAGR of 8.8% to reach USD 16.1 billion by 2034, driven by the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular conditions. As the demand for long-term treatments, including biologics, vaccines, and other sensitive pharmaceuticals, rises, the need for lyophilization equipment grows.
Lyophilization is an essential process in the pharmaceutical and biopharmaceutical industries, as it helps preserve the efficacy, stability, and shelf life of sensitive therapeutics, including vaccines, biologics, and injectables. By removing moisture through freeze-drying, lyophilization ensures that these products maintain their integrity over extended periods, even under challenging storage conditions. This process is especially vital for chronic conditions that require long-term or ongoing treatment, such as cancer, diabetes, and cardiovascular diseases. As the global prevalence of these conditions continues to rise, the need for lyophilized products is expected to increase significantly. The demand for these long-lasting, moisture-free therapeutics has a direct impact on the growth of the lyophilization equipment market. As pharmaceutical and biopharmaceutical companies continue to develop new treatments that require specialized storage solutions, the reliance on lyophilization processes will grow.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $7 Billion |
Forecast Value | $16.1 Billion |
CAGR | 8.8% |
The devices segment generated USD 3.7 billion in 2024, driven by the increasing demand for automated, high-throughput, and energy-efficient freeze-drying equipment, such as rotary freeze dryers and tray-style dryers. These devices are especially useful in large-scale production of heat-sensitive products, including biologics and vaccines. Furthermore, continuous advancements in lyophilization technologies, such as real-time monitoring capabilities and improved control over critical parameters like temperature and vacuum, are enhancing the efficiency of these devices, making them more attractive to the pharmaceutical and biopharmaceutical sectors.
The bench-top lyophilization equipment segment held a 46.3% share in 2024 and is set to reach USD 7.5 billion by 2034. Bench-top units are favored in small-scale production settings, such as laboratories, pharmaceutical development, and academic research institutions, due to their compact design, cost-effectiveness, and advanced features, including precise vacuum and temperature control. These qualities make bench-top lyophilization equipment ideal for experimental studies and early-stage formulation development.
United States Lyophilization Equipment Market is expected to reach USD 4.7 billion by 2034, driven by the rising prevalence of cancer in the country. As cancer treatment continues to evolve, many pharmaceutical and biotechnology companies are investing in the development of stable, advanced therapies like vaccines and injectables. Lyophilization technology supports the large-scale production of these oncology treatments, further fueling market expansion.
Key players in the Global Lyophilization Equipment Market include companies such as Azbil, GEA Group Aktiengesellschaft, MechaTech Systems, Millrock Technology, and W. L. Gore & Associates. These companies are focusing on innovation and expanding their product offerings to strengthen their position in the market. For instance, firms like Labconco and ZIRBUS technology are emphasizing energy-efficient and user-friendly solutions, while companies such as Optima and Cuddon are exploring the integration of advanced monitoring systems and automation to improve device performance and reliability.